Study about treatment of aneamis of dialyzed patients in France (1998-1999) (Study ESAM-France);Enquête sur le traitement de l'anémie des patients dialysés en France (1998-1999) (Etude ESAM-France)

Nephrologie

Volumn 23, Issue 2, 2002, Pages 85-91

  Jacobs, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anemia; Chronic renal failure; Dialysis; Erythropoietin

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; DIALYSIS; DRUG INDUCED DISEASE; EUROPE; FRANCE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PERITONEAL DIALYSIS;

ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FRANCE; HEMOGLOBINS; HUMANS; RENAL DIALYSIS;

EID: 0036214484     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hematocrit level and associated mortality in hemodialysis patients
2. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
3. Clinical practice guidelines for the treatment of anemia of chronic renal failure
4. European best practice guidelines for the management of anaemia in patients with chronic renal failure
5. European survey on anaemia management
6. Intravenous iron for CAPD populations: Practice or reactive strategies
7. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
8. Intravenous administration of iron in epoietin-treated haemodialysis patients. Which drugs, which regimen?